SHL Telemedicine Ltd. (SHLT)
2.05
0.00 (0.00%)
At close: Apr 02, 2025, 10:51 AM
0.00% (1D)
| Bid | 1.77 |
| Market Cap | 33.6M |
| Revenue (ttm) | 55.94M |
| Net Income (ttm) | -8.84M |
| EPS (ttm) | -0.53 |
| PE Ratio (ttm) | -3.87 |
| Forward PE | -10.75 |
| Analyst | Buy |
| Ask | 2.43 |
| Volume | 1,678 |
| Avg. Volume (20D) | 5,095 |
| Open | 2.10 |
| Previous Close | 2.05 |
| Day's Range | 2.05 - 2.05 |
| 52-Week Range | 1.85 - 6.08 |
| Beta | 0.29 |
About SHLT
SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device f...
Sector Healthcare
IPO Date Apr 3, 2023
Employees 583
Stock Exchange NASDAQ
Ticker Symbol SHLT
Website https://www.shl-telemedicine.com
Analyst Forecast
According to 1 analyst ratings, the average rating for SHLT stock is "Buy." The 12-month stock price forecast is $11, which is an increase of 436.59% from the latest price.
Stock Forecasts